Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.[#item_full_content]
Hormuz crisis hides a deeper oil threat that could outlast the war
Agosto 25, 2026
As global attention remains fixed on tankers moving through the Strait of Hormuz, a petroleum geologist is warning that the more consequential energy story may
